Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for motility and strength in myotonic dystrophy type 1
2018-000692-32Phase 3Completed
- Sponsor
- University of Rome Tor Vergata, Department of Systems Medicine
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myotonic dystrophy type 1 (DM1) comparing Metformin with Placebo (2 arms). Started Jan 2020; status: completed.
02
Drugs
metformin
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on 2018-000692-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000692-32.